‘Medical Device Injury’ Category

IVC Filter Lawsuits Consolidated in Federal Court

Hundreds of IVC filter lawsuits against C.R. Bard Inc. (Bard) have been transferred to a federal multi-district litigation (MDL) judge in Phoenix, Arizona. To date, more than 400 blood clot filter cases have been filed in federal court against the New Jersey-based medical device maker. Bard has marketed and sold its IVC blood clot filters as a way to capture blood clots before they reach the...

700 Sue Metal-on-Metal Hip Manufacturers in Britain

Metal-on-Metal Hip Implant

Seven hundred Britains have filed a massive metal-on-metal hip implant lawsuit against three makers of the dangerously defective implants. The defendants in the case reportedly include: Zimmer, which made the Durom cup implant; DePuy, the Johnson & Johnson subsidiary that made the Pinnacle system; and Corin, which manufactured the Cormet hip replacement system. Metal-on-metal hip implants...

Cost and Risk of IVC Filters Outweigh Benefits for Many

Inferior vena caval (IVC) filters are not worth the cost and risk involved to justify their widespread use, concludes a study by Yale researchers published in the March 2016 issue of the Journal of the American College of Cardiology. IVC filters are implanted in the body in an effort to prevent pulmonary embolism, in which blood flow in the arteries is blocked by air or blood clots. The...

Transvaginal Mesh Maker to Shut Down

The Astora Women’s Health division of Endo International PLC is calling it quits as the division faces thousands of transvaginal mesh lawsuits. Endo is just one manufacturer of dangerous vaginal mesh — implanted in thousands of women suffering from pelvic organ prolapse or urinary incontinence. Unfortunately, the medical device often does more to hurt than to help. Transvaginal mesh may...

Ban Transvaginal Mesh, California Women Urge

Around 100,000 women have filed transvaginal mesh (TVM) lawsuits against Johnson & Johnson, Bard, Boston Scientific and others as a result of severe and debilitating injuries they’ve suffered after being implanted with TVM. In January, the U.S. Food and Drug Administration announced a new warning about vaginal mesh, now classifying the device as “high risk.” Transvaginal mesh is...

Discovery Schedule Proposed in Bard IVC Filter Lawsuits

A discovery schedule has been proposed in the roughly 100 IVC Filter lawsuits pending in a federal MDL in Arizona before U.S. District Judge David G. Campbell. The medical device lawsuits include claims based on injuries caused by the Bard Recovery, G2, and G2 Express retrievable filters. The discovery schedule would apply to the earliest cases filed in the MDL. Those cases might see a trial...

Stricter Requirements for Metal-On-Metal Hip Implants

Metal-on-metal hip replacement manufacturers must now submit a premarket approval application (PMA) to the U.S. Food and Drug Administration for two types of hip systems, one having a cemented acetabular component and the other having an uncemented acetabular component. The FDA’s final order released this past February reportedly gives medical device makers until May 18 to submit their new...

Bard Sold Blood Clot Filters Despite Dangers

What did medical device maker C.R. Bard do after it learned problems existed with its blood clot filter? The medical device in question was developed to replace a different filter implicated in the deaths of 27 people? Bard continued selling the filters — more than 160,000 of them in a five-year period.

Bard is a New Jersey-based corporation that manufacturers medical devices,...

Study Examines Mix-And-Match Hip Replacement Surgeries

Orthopedic surgeons in Europe will often mix-and-match components when performing hip replacement surgery. This is happening in spite of warnings against the practice from manufacturers of metal-on-metal and other hip systems. This was the finding of Dr. Keith Tucker, an orthopedic surgeon in Norwich, United Kingdom, and his colleagues, who conducted a recent study to learn how many total hip...

New IVC Filter Clinical Trial to Study Potential Risks

January 21, 2016 – Patients are now being enrolled in a new study to assess the effectiveness and safety of inferior vena cava (IVC) filters — small medical devices implanted in the body to stop blood clots from reaching the heart or lungs. The five-year-long study will involve 2,100 patients at 60 medical sites around the country. PRESERVE (Predicting the Safety and Effectiveness of...

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880